Sector
PharmaceuticalsOpen
₹476.9Prev. Close
₹474.6Turnover(Lac.)
₹1,034.94Day's High
₹488.55Day's Low
₹473.1552 Week's High
₹658.8552 Week's Low
₹366.25Book Value
₹145.62Face Value
₹1Mkt Cap (₹ Cr.)
7,809.19P/E
28.54EPS
16.81Divi. Yield
2.08Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 16.28 | 16.59 | 16.88 | 16.88 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,080.92 | 1,964.15 | 1,931.8 | 1,705.28 |
Net Worth | 2,097.2 | 1,980.74 | 1,948.68 | 1,722.16 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 1,325.44 | 1,331.09 | 1,062.19 | 1,008.91 |
yoy growth (%) | -0.42 | 25.31 | 5.28 | 2.23 |
Raw materials | -412.05 | -424.53 | -349.97 | -336.73 |
As % of sales | 31.08 | 31.89 | 32.94 | 33.37 |
Employee costs | -294.31 | -276.18 | -215.46 | -189.93 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 380.45 | 325.45 | 233.9 | 255.66 |
Depreciation | -37.62 | -37.36 | -35.03 | -34.52 |
Tax paid | -85.96 | -78.68 | -65.59 | -62.71 |
Working capital | 22.62 | 78.25 | 14.4 | 16.61 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -0.42 | 25.31 | 5.28 | 2.23 |
Op profit growth | 14.36 | 29.42 | -9.44 | 6.6 |
EBIT growth | 16.71 | 39.76 | -8.46 | 10.17 |
Net profit growth | 19.33 | 46.61 | -10.02 | 10.75 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 2,108.12 | 1,942.94 | 1,783.75 | 1,527.92 | 1,333.2 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,108.12 | 1,942.94 | 1,783.75 | 1,527.92 | 1,333.2 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 90.66 | 101.63 | 49.86 | 76.09 | 97.03 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Mohan A Chandavarkar
Executive Director
Ashok A Chandavarkar
Joint Managing Director
Nandan M Chandavarkar
Executive Director & CEO
Ameya A Chandavarkar
Chairman Emeritus
Ramdas A Chandavarkar
Company Sec. & Compli. Officer
Varsharani Katre
Non Executive Director
Nomita R Chandavarkar
Chairman & Independent Directo
Uday Kumar Gurkar
Independent Director
Mahesh Bijlani
Independent Director
Vijay Maniar
Independent Director
Swati S Mayekar
Independent Director
Vijay N Bhatt
Independent Director
Charuta Nityanath Mandke
B-8 MIDC Industrial Area,
Waluj Dist,
Maharashtra - 431136
Tel: 91-240-2554407/967/299
Website: http://www.fdcindia.com
Email: [email protected]; [email protected]
Unit No 1 Luthra Ind,
Andheri Kurla Road, Safed Pool Andheri(E,
Mumbai - 400 072
Tel: 91-22-2851 5606
Website: www.sharexindia.com
Email: [email protected]
Summary
FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (AP...
Read More
Reports by FDC Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.